Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sacha Spelier

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 8, 2026
Ageing with cystic fibrosis: Challenges aheadSacha Spelier, Maud I M van der Wijst, Isabelle Fajac, et al.
Journal of Clinical Medicine|November 8, 2019
Patient-Derived Head and Neck Cancer Organoids Recapitulate EGFR Expression Levels of Respective Tissues and Are Responsive to EGFR-Targeted Photodynamic TherapyElse Driehuis, Sacha Spelier, Irati Beltrán Hernández, et al.
Trends in Molecular Medicine|February 24, 2023
Readthrough compounds for nonsense mutations: bridging the translational gapSacha Spelier, Eveline P M van Doorn, Cornelis K van der Ent, et al.
Frontiers in Molecular Biosciences|October 4, 2021
CFTR Rescue in Intestinal Organoids with GLPG/ABBV-2737, ABBV/GLPG-2222 and ABBV/GLPG-2451 Triple TherapyEyleen de Poel, Sacha Spelier, Ricardo Korporaal, et al.
International Journal of Neonatal Screening|July 23, 2025
The Promising Role of Intestinal Organoids in the Diagnostic Work-Up of Cystic Fibrosis Screen Positive Inconclusive Diagnosis/CFTR-Related Metabolic Syndrome (CFSPID/CRMS)Noelia Rodriguez Mier, Marlies Destoop, Sacha Spelier, et al.
Pediatric Pulmonology|April 6, 2026
Patient-Derived Intestinal Organoids in the Global Cystic Fibrosis LandscapeSuzanne Kroes, Jennifer L Taylor-Cousar, Marco Zampoli, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 16, 2026
A functional comparison of vanzacaftor/tezacaftor/deutivacaftor and elexacaftor/tezacaftor/ivacaftor in patient-derived intestinal organoids with rare CFTR variantsSuzanne Kroes, Lara Zaidi, Heleen N Sonneveld-van Kooten, et al.
Nucleic Acids Research|July 12, 2025
ACE-tRNAs are a platform technology for suppressing nonsense mutations that cause cystic fibrosisWooree Ko, Joseph J Porter, Sacha Spelier, et al.
ERJ Open Research|February 2, 2023
High-throughput functional assay in cystic fibrosis patient-derived organoids allows drug repurposingSacha Spelier, Eyleen de Poel, Georgia N Ithakisiou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 15, 2023
Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosisCatherine Leroy, Sacha Spelier, Nadège Charlene Essonghe, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 8, 2026
Ageing with cystic fibrosis: Challenges aheadSacha Spelier, Maud I M van der Wijst, Isabelle Fajac, et al.
Journal of Clinical Medicine|November 8, 2019
Patient-Derived Head and Neck Cancer Organoids Recapitulate EGFR Expression Levels of Respective Tissues and Are Responsive to EGFR-Targeted Photodynamic TherapyElse Driehuis, Sacha Spelier, Irati Beltrán Hernández, et al.
Trends in Molecular Medicine|February 24, 2023
Readthrough compounds for nonsense mutations: bridging the translational gapSacha Spelier, Eveline P M van Doorn, Cornelis K van der Ent, et al.
Frontiers in Molecular Biosciences|October 4, 2021
CFTR Rescue in Intestinal Organoids with GLPG/ABBV-2737, ABBV/GLPG-2222 and ABBV/GLPG-2451 Triple TherapyEyleen de Poel, Sacha Spelier, Ricardo Korporaal, et al.
International Journal of Neonatal Screening|July 23, 2025
The Promising Role of Intestinal Organoids in the Diagnostic Work-Up of Cystic Fibrosis Screen Positive Inconclusive Diagnosis/CFTR-Related Metabolic Syndrome (CFSPID/CRMS)Noelia Rodriguez Mier, Marlies Destoop, Sacha Spelier, et al.
Pediatric Pulmonology|April 6, 2026
Patient-Derived Intestinal Organoids in the Global Cystic Fibrosis LandscapeSuzanne Kroes, Jennifer L Taylor-Cousar, Marco Zampoli, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 16, 2026
A functional comparison of vanzacaftor/tezacaftor/deutivacaftor and elexacaftor/tezacaftor/ivacaftor in patient-derived intestinal organoids with rare CFTR variantsSuzanne Kroes, Lara Zaidi, Heleen N Sonneveld-van Kooten, et al.
Nucleic Acids Research|July 12, 2025
ACE-tRNAs are a platform technology for suppressing nonsense mutations that cause cystic fibrosisWooree Ko, Joseph J Porter, Sacha Spelier, et al.
ERJ Open Research|February 2, 2023
High-throughput functional assay in cystic fibrosis patient-derived organoids allows drug repurposingSacha Spelier, Eyleen de Poel, Georgia N Ithakisiou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 15, 2023
Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosisCatherine Leroy, Sacha Spelier, Nadège Charlene Essonghe, et al.
Pageof 2